Halo (Biotechnology) Overview
- Year Founded
-
2005
- Status
-
Private
- Employees
-
44
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$280K
- Investors
-
2
Halo (Biotechnology) General Information
Description
Operator of a biotechnology company intended to deliver an optimized alternative for liquid chromatographic separations. The company specializes in separation sciences focused on groundbreaking technology in novel superficially porous particle development with high efficiency and reliability for scientists involved in both small and large molecule separations, enabling research scientists to deliver innovative tools to enhance the separation resolution afforded by the column technology.
Contact Information
Website
www.halocolumns.comCorporate Office
- 3521 Silverside Road, Quillen Building
- Suite 1-K
- Wilmington, DE 19810
- United States
Corporate Office
- 3521 Silverside Road, Quillen Building
- Suite 1-K
- Wilmington, DE 19810
- United States
Halo (Biotechnology) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Grant | 01-Apr-2021 | $280K | Completed | Generating Revenue | ||
| 4. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 3. Debt - PPP | 07-Apr-2020 | Completed | Generating Revenue | |||
| 2. Grant | 01-Jan-2018 | $7.97M | $350K | Completed | Generating Revenue | |
| 1. Early Stage VC | 31-Dec-2007 | $350K | $350K | Completed | Generating Revenue |
Halo (Biotechnology) Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Halo (Biotechnology) Patents
Halo (Biotechnology) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025250776-A1 | A ph stable chromatographic material and method of producing the same | Pending | 29-May-2024 | ||
| WO-2025188393-A1 | Hydrophobic interaction chromatography (hic) composition and method of producing the hic composition | Pending | 06-Mar-2024 | ||
| WO-2025188393-A8 | Hydrophobic interaction chromatography (hic) composition and method of producing the hic composition | Pending | 06-Mar-2024 | ||
| EP-4662004-A1 | Chromatographic composition and methods of producing the chromatographic composition | Pending | 10-Feb-2023 | ||
| US-20260216699-A1 | Chromatographic composition and methods of producing the chromatographic composition | Pending | 10-Feb-2023 | B01J20/3227 |
Halo (Biotechnology) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Halo (Biotechnology) Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Institutes of Health | Government | |||
| Jumpstart Ventures | Venture Capital | Minority |
Halo (Biotechnology) FAQs
-
When was Halo (Biotechnology) founded?
Halo (Biotechnology) was founded in 2005.
-
Where is Halo (Biotechnology) headquartered?
Halo (Biotechnology) is headquartered in Wilmington, DE.
-
What is the size of Halo (Biotechnology)?
Halo (Biotechnology) has 44 total employees.
-
What industry is Halo (Biotechnology) in?
Halo (Biotechnology)’s primary industry is Biotechnology.
-
Is Halo (Biotechnology) a private or public company?
Halo (Biotechnology) is a Private company.
-
What is Halo (Biotechnology)’s current revenue?
The current revenue for Halo (Biotechnology) is .
-
How much funding has Halo (Biotechnology) raised over time?
Halo (Biotechnology) has raised $350K.
-
Who are Halo (Biotechnology)’s investors?
National Institutes of Health and Jumpstart Ventures have invested in Halo (Biotechnology).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
